Printer Friendly

Echevarne to distribute Natera's prenatal screening test in Spain.

M2 PHARMA-May 15, 2013-Echevarne to distribute Natera's prenatal screening test in Spain(C)2013 M2 COMMUNICATIONS

15 May 2013 - US genetic testing company Natera Inc has picked Spanish clinical analysis laboratory Echevarne as a distrubitor of its non-invasive prenatal screening test (NIPT), Panorama, in Spain, the parties said today.

The test, introduced in March, detects trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), as well as sex chromosome abnormalities, including monosomy X (Turner's syndrome).

Panorama targets 19,500 single nucleotide polymorphisms (SNPs), using Natus, an advanced version of Natera's proprietary informatics.

The assay is now being tested in clinical studies for detection of other genetic disorders, such as XXY, XYY, XXX and triploidy.

((Comments on this story may be sent to

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Geographic Code:4EUSP
Date:May 15, 2013
Previous Article:University of York spin-off, Fujirebio Diagnostics to develop diagnostic test for lung cancer - report.
Next Article:i"?Sorrento Therapeutics and Igdrasol acquire distribution rights for Cynviloq.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters